You are here
Found 85 results
Filters: keyword is Animals [Clear All Filters]
2007
.
2007. 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.
Bioorg. & Med. Chem. Lett.. 17(9):2523-2526. Abstract
.
2007. A live Salmonella enterica serovar Enteritidis vaccine allows serological differentiation between vaccinated and infected animals.
75(5):2461-2468. Abstract
.
2007. The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex.
581(4):687-692. Abstract
.
2007. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
7:22. Abstract
.
2007. Combining sites of bacterial fimbriae.
Current opinion in structural biology. 17(5):506-512. Abstract
2006
.
2006. Arsenate reduction: thiol cascade chemistry with convergent evolution.
J. Mol. Biol.. 362(1):1-17. Abstract
.
2006. Multiple transients in the pre-steady-state of nucleoside hydrolase reveal complex substrate binding, product base release, and two apparent rates of chemistry.
Biochemistry. 45(30):9307-9318. Abstract
.
2006. Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
Journal Molecular Biology. 359(2):331-346. Abstract
.
2006. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.
103(12):4586-4591. Abstract
.
2006. Pathways of disulfide bond formation in Escherichia coli.
Int. J. Biochem. Cell Biol.. 38(7):1050-1062. Abstract
2005
.
2005. Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system.
Nanoletters. 5(11):2220-2224. Abstract
.
2005. Crystallization and preliminary X-ray analysis of the Man(alpha1-2)Man-specific lectin from Bowringia mildbraedii in complex with its carbohydrate ligand.
61(Pt 10):931-934. Abstract
.
2005. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
352(3):597-607. Abstract
.
2005. Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.
350(1):112-125. Abstract
.
2005. Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavage.
J. Biol. Chem. 280(15):14799-14802. Abstract
.
2005. Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires.
280(14):14114-14121. Abstract
.
2005. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
Nature. 346(3):773-788. Abstract
2004
.
2004. Chemical basis for the affinity maturation of a camel single domain antibody.
279(51):53593-53601. Abstract
.
2004. NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.
271(16):3399-3413. Abstract
.
2004. Solution structure of the pore-forming protein of Entamoeba histolytica.
279(17):17834-17841. Abstract
.
2004. Leaving group activation by aromatic stacking: an alternative to general acid catalysis.
J. Mol. Biol. 338(1):1-6. Abstract
.
2004. Detection and characterization of partially unfolded oligomers of the SH3 domain of alpha-spectrin.
86(4):2403-2413. Abstract
.
2004. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.
279(2):1256-1261. Abstract
2003
.
2003. Pre-steady-state analysis of the nucleoside hydrolase of Trypanosoma vivax. Evidence for half-of-the-sites reactivity and rate-limiting product release.
Biochemistry. 42(44):12902-12908. Abstract
.
2003. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.
424(6950):783-788. Abstract